Convergent mechanisms in etiologically-diverse dystonias

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 12, 2011, Pages 1387-1403

  Thompson, Valerie B ^a   Jinnah, H A ^a   Hess, Ellen J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

basal ganglia; calcium; cerebellum; dopamine; dystonia; mitochondria; plasticity

Indexed keywords

BASAL GANGLION; CALCIUM SIGNALING; CAUSAL ATTRIBUTION; CEREBELLUM; CLINICAL FEATURE; DOPAMINERGIC SYSTEM; DYSTONIA; HUMAN; MOTOR DYSFUNCTION; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; REVIEW; SENSORIMOTOR FUNCTION;

ANIMALS; BRAIN; CALCIUM; DOPAMINE; DYSTONIA; HUMANS; MITOCHONDRIA; NEURONAL PLASTICITY;

EID: 83655202797     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2011.641533     Document Type: Review

References (205)

1. Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol 2004;94:163-70
2. Bruno MK, Ravina B, Garraux G, et al. Exercise-induced dystonia as a preceding symptom of familial Parkinsons disease. Mov Disord 2004;19:228-30 (Pubitemid 38312711)
3. McKeon A, Matsumoto JY, Bower JH, et al. The spectrum of disorders resenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat. Disord. 2008;14:613-19
4. Papapetropoulos S, Lundy DS, Casiano RR, et al. Laryngeal dystonia as a presenting symptom of young-onset Parkinsons disease. Mov Disord 2007;22:1670-1 (Pubitemid 47477940)
5. Katchen M, Duvoisin RC. Parkinsonism following dystonia in three patients. Mov Disord 1986;1:151-7
6. Lees AJ, Hardie RJ, Stern GM. Kinesigenic foot dystonia as a presenting feature of Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 1984;47:885
7. Klawans HL, Paleologos N. Dystonia-Parkinson syndrome: Differential effects of levodopa and dopamine agonists. Clin. Neuropharmacol. 1986;9:298-302 (Pubitemid 16022861)
8. Lopez-Ariztegui N, Arevalo MA, de Ceballos ML, et al. Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias. Clin. Neuropharmacol. 2009;32:321-5
9. Bravi D, Mouradian MM, Roberts JW, et al. End-of-dose dystonia in Parkinsons disease. Neurology 1993;43:2130-1
10. Cubo E, Gracies JM, Benabou R, et al. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol 2001;58:1379-82 (Pubitemid 32845988)
11. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32:1335-46 (Pubitemid 13203738)
12. Tonini M, Cipollina L, Poluzzi E, et al. Review article: Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol. Ther. 2004;19:379-90 (Pubitemid 38297106)
13. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998;121:2053-66 (Pubitemid 28497904)
14. Abeling NG, Duran M, Bakker HD, et al. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol. Genet. Metab. 2006;89:116-20 (Pubitemid 44205465)
15. Furukawa Y, Shimadzu M, Rajput AH, et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann. Neurol. 1996;39:609-17
16. Hanihara T, Inoue K, Kawanishi C, et al. 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: A clinical and molecular study. Mov Disord 1997;12:408-11 (Pubitemid 27216141)
17. Knappskog PM, Flatmark T, Mallet J, et al. Recessively inherited L-DOPAresponsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 1995;4:1209-12
18. Ludecke B, Knappskog PM, Clayton PT, et al. Recessively inherited L-DOPAresponsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 1996;57:1023-8 (Pubitemid 26232286)
19. Neville BG, Parascandalo R, Farrugia R, et al. Sepiapterin reductase deficiency: A congenital dopa-responsive motor and cognitive disorder. Brain 2005;128:2291-6 (Pubitemid 41407969)
20. Thony B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4adehydratase, and dihydropteridine reductase. Hum. Mutat. 2006;279:870-8 (Pubitemid 44336936)
21. Muller K, Homberg V, Lenard HG. Motor control in childhood onset dopa-responsive dystonia (Segawa syndrome). Neuropediatrics 1989;20:185-91 (Pubitemid 19284902)
22. Boyd K, Patterson V. Dopa responsive dystonia: A treatable condition misdiagnosed as cerebral palsy. BMJ 1989;298:1019-20 (Pubitemid 19102786)
23. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 1994;8:236-42 (Pubitemid 24338734)
24. van den Heuvel LP, Luiten B, Smeitink JA, et al. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPAresponsive dystonia in the Dutch population. Hum. Genet. 1998;102:644-6 (Pubitemid 28362760)
25. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 1996;334:1568-72 (Pubitemid 26177484)
26. Nyhan WL. Dopamine function in Lesch-Nyhan disease. Environ Health Perspect 2000;108:409-11 (Pubitemid 30466165)
27. Lloyd KG, Hornykiewicz O, Davidson L, et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N EnglJ Med 1981;305:1106-11 (Pubitemid 11031666)
28. Saito Y, Ito M, Hanaoka S, et al. Dopamine receptor upregulation in Lesch-Nyhan syndrome: A postmortem study. Neuropediatrics 1999;30:66-71 (Pubitemid 29265402)
29. Jinnah HA, Wojcik BE, Hunt M, et al. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 1994;14:1164-75 (Pubitemid 24081913)
30. Ceballos-Picot I, Mockel L, Potier MC, et al. Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: Implications for Lesch-Nyhan disease pathogenesis. Hum Mol Gen 2009;18:2317-27
31. Barnett MH, Jarman PR, Heales SJ, et al. Further case of paroxysmal exercise-induced dystonia and some insights into pathogenesis. Mov Disord 2002;17:1386-7 (Pubitemid 36041364)
32. Hamann M, Richter A. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia. Neurobiol. Dis. 2004;16:78-84 (Pubitemid 38569798)
33. Napolitano F, Pasqualetti M, Usiello A, et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol. Dis. 2010;38:434-45
34. Sciamanna G, Bonsi P, Tassone A, et al. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol. Dis. 2009;34:133-45
35. Neychev VK, Fan X, Mitev VI, et al. The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 2008;131:2499-509
36. Horie C, Suzuki Y, Kiyosawa M, et al. Decreased dopamine D-2 receptor binding in essential blepharospasm. Acta Neurol Scand 2009;119:49-54
37. Hierholzer J, Cordes M, Schelosky L, et al. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis. J Nucl Med 1994;35:1921-7 (Pubitemid 24376604)
38. Naumann M, Pirker W, Reiners K, et al. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: A SPECTstudy using [123I] epidepride and [123I] beta-CIT. Mov Disord 1998;13:319-23
39. Boesch SM, Donnemiller E, Muller J, et al. Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I-betaCIT and 123I-IBZM SPECTstudy. Mov Disord 2004;19:1320-5 (Pubitemid 39534550)
40. Berger HJ, van der Werf SP, Horstink CA, et al. Writer's cramp: Restoration of striatal D2-binding after successful biofeedback-based sensorimotor training. Parkinsonism Relat. Disord. 2007;13:170-3 (Pubitemid 46436561)
41. Lang AE. Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol 1988;50:561-70
42. Mandell S. The treatment of dystonia with L-dopa and haloperidol. Neurology 1970;20:103-6
43. Thiel A, Dressler D, Kistel C, et al. Clozapine treatment of spasmodic torticollis. Neurology 1994;44:957-8 (Pubitemid 24158818)
44. Barrett RE, Yahr MD, Duvoisin RC. Torsion dystonia and spasmodic torticollis - results of treatment with Ldopa. Neurology 1970;20:107-13
45. Grassi E, Latorraca S, Piacentini S, et al. Risperidone in idiopathic and symptomatic dystonia: Preliminary experience. Neurol Sci 2000;21:121-3 (Pubitemid 30457281)
46. Gourzis P, Polychronopoulos P, Papapetropoulos S, et al. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: A report of 2 cases. Clin. Neuropharmacol. 2005;28:195-6 (Pubitemid 41134250)
47. Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 1988;3:46-60
48. Ming L. Moldy sugarcane poisoning - a case report with a brief review. J Toxicol Clin Toxicol 1995;33:363-7
49. He F, Zhang S, Qian F, et al. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3- nitropropionic acid). Neurology 1995;45:2178-83 (Pubitemid 27100244)
50. Peraica M, Radic B, Lucic A, et al. Toxic effects of mycotoxins in humans. Bull World Health Organ 1999;77:754-66 (Pubitemid 29477027)
51. Beal MF, Brouillet E, Jenkins BG, et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-92 (Pubitemid 23299942)
52. Herrera-Mundo N, Sitges M. Mechanisms underlying striatal vulnerability to 3-nitropropionic acid. J Neurochem 2010;114:597-605
53. Fernagut PO, Diguet E, Stefanova N, et al. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 2002;114:1005-17
54. Palfi S, Leventhal L, Goetz CG, et al. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord 2000;15:524-30 (Pubitemid 30333226)
55. Brouillet E, Hantraye P, Ferrante RJ, et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 1995;92:7105-9
56. De Vries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am. J. Hum. Genet. 1996;58:703-11 (Pubitemid 26086659)
57. Sarzi E, Brown MD, Lebon S, et al. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am. J. Med Genet A 2007;143:33-41 (Pubitemid 46051469)
58. Huoponen K, Vilkki J, Aula P, et al. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am. J. Hum. Genet. 1991;48:1147-53
59. Makino M, Horai S, Goto Y, et al. Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome. Neuromuscul Disord 1998;8:149-51 (Pubitemid 28246109)
60. Santorelli FM, Shanske S, Macaya A, et al. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann. Neurol. 1993;34:827-34 (Pubitemid 23357897)
61. Roesch K, Curran SP, Tranebjaerg L, et al. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum. Mol. Genet. 2002;11:477-86 (Pubitemid 34257484)
62. Tranebjaerg L, Jensen PK, Van Ghelue M, et al. Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene. Ophthalmic Genet 2001;22:207-23 (Pubitemid 34497302)
63. Binder J, Hofmann S, Kreisel S, et al. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. Brain 2003;126:1814-20 (Pubitemid 36917340)
64. Ezquerra M, Campdelacreu J, Munoz E, et al. A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome. Arch Neurol 2005;62:306-8 (Pubitemid 40204753)
65. Arts WFM, Scholte HR, Bogaard JM, et al. NADH-CoQ reductase deficient myopathy - Successful treatment with riboflavin. Lancet 1983;2:581-2 (Pubitemid 13041597)
66. Bernsen P, Gabreels FJM, Ruitenbeek W, et al. Treatment of complex-I deficiency with riboflavin. J. Neurol. Sci. 1993;118:181-7
67. Penn AMW, Lee JWK, Thuillier P, et al. Melas Syndrome with mitochondrial transfer RNALue(UUR) mutation -correlation of clinical state, nerve-conduction, and muscle P-31 magnetic-resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 1992;42:2147-52
68. Benecke R, Strumper P, Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann. Neurol. 1992;32:683-6
69. Nigro MA, Martens ME, Awerbuch GI, et al. Partial cytochrome b deficiency and generalized dystonia. Pediatr Neurol 1990;6:407-10
70. Schapira AH, Warner T, Gash MT, et al. Complex I function in familial and sporadic dystonia. Ann. Neurol. 1997;41:556-9 (Pubitemid 27169197)
71. Simon DK, Friedman J, Breakefield XO, et al. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics 2003;4:199-205 (Pubitemid 37122221)
72. Pettus EH, Betarbet R, Cottrell B, et al. Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH: ubiquinone oxidoreductase) in rat brain. J Neurochem 2000;75:383-92 (Pubitemid 30418206)
73. Solano A, Roig M, Vives-Bauza C, et al. Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene. Ann. Neurol. 2003;54:527-30 (Pubitemid 37176551)
74. Bruyn GW, Vielvoye GJ, Went LN. Hereditary spastic dystonia: A new mitochondrial ncephalopathy? Putaminal necrosis as a diagnostic sign. J. Neurol. Sci. 1991;103:195-202
75. Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 2004;279:18614-22 (Pubitemid 38623283)
76. Cuenca-Leon E, Banchs I, Serra SA, et al. Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. J. Neurol. Sci. 2009;280:10-14
77. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: Four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 2002;44:490-3 (Pubitemid 34808757)
78. Roubertie A, Echenne B, Leydet J, et al. Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J Neurol 2008;255:1600-2
79. Spacey SD, Materek LA, Szczygielski BI, et al. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 2005;62:314-16 (Pubitemid 40204755)
80. Vesper J, Klostermann F, Funk T, et al. Deep brain stimulation of the globus pallidus internus (GPI) for torsion dystonia - a report of two cases.Acta Neurochir Suppl 2002;79:83-8
81. Bereznai B, Steude U, Seelos K, et al. Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: A clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia. Mov Disord 2002;17:138-44 (Pubitemid 36041270)
82. McIntyre CC, Grill WM, Sherman DL, et al. Cellular effects of deep brain stimulation: Model-based analysis of activation and inhibition. J Neurophysiol 2004;91:1457-69 (Pubitemid 38339318)
83. 2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha1A-subunit. Proc Natl Acad Sci USA 1999;96:15245-50 (Pubitemid 30019797)
84. Fletcher CF, Tottene A, Lennon VA, et al. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J 2001;15:1288-90
85. Raike RS, Jinnah HA, Hess EJ. Animal models of generalized dystonia. NeuroRx 2005;2:504-12 (Pubitemid 41444884)
86. Xie G, Clapcote SJ, Nieman BJ, et al. Forward genetic screen of mouse reveals dominant missense mutation in the P/Qtype voltage-dependent calcium channel, CACNA1A. Genes Brain Behav 2007;6:717-27 (Pubitemid 350043943)
87. Doyle J, Ren X, Lennon G, et al. Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice. Mamm Genome 1997;8:113-20 (Pubitemid 28060718)
88. Lorenzon NM, Lutz CM, Frankel WN, et al. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner. J Neurosci 1998;18:4482-9 (Pubitemid 28280159)
89. Shirley TL, Rao LM, Hess EJ, et al. Paroxysmal dyskinesias in mice. Mov Disord 2008;23:259-64 (Pubitemid 351311557)
90. Zwingman TA, Neumann PE, Noebels JL, et al. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J Neurosci 2001;21:1169-78 (Pubitemid 32128762)
91. Wakamori M, Yamazaki K, Matsunodaira H. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J. Biol. Chem. 1998;273:34857-67 (Pubitemid 29028180)
92. Pietrobon D. CaV2.1 channelopathies. Pflugers Arch 2010;460:375-93
93. Jinnah HA, Sepkuty JP, Ho T, et al. Calcium channel agonists and dystonia in the mouse. Mov Disord 2000;15:542-51 (Pubitemid 30333229)
94. Fureman BE, Jinnah HA, Hess EJ. Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol. Biochem. Behav. 2002;73:631-7 (Pubitemid 34876714)
95. 2+ channel antagonists in a hamster model of idiopathic dystonia. Eur J Pharmacol 1996;300:197-202
96. Wszolek ZK, Baba Y, Mackenzie IR, et al. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology 2006;67:620-5 (Pubitemid 44273608)
97. Du W, Bautista JF, Yang H, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat. Genet. 2005;37:733-8 (Pubitemid 41754890)
98. Neychev VK, Gross RE, Lehericy S, et al. The functional neuroanatomy of dystonia. Neurobiol. Dis. 2011;42:185-201
99. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-76 (Pubitemid 24281846)
100. Kurita H, Sasaki T, Suzuki I, et al. Basal ganglia arteriovenous malformation presenting as "writer's cramp". Childs Nerv Syst 1998;14:285-7 (Pubitemid 28317419)
101. Mahant N, Cordato DJ, Fung VS. Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: Clinical and neurophysiological features. Mov Disord 2003;18:452-5
102. Munchau A, Mathen D, Cox T, et al. Unilateral lesions of the globus pallidus: Report of four patients presenting with focal or segmental dystonia. J. Neurol. Neurosurg. Psychiatry 2000;69:494-8
103. Walker RH, Purohit DP, Good PF, et al. Severe generalized dystonia due to primary putaminal degeneration: Case report and review of the literature. Mov Disord 2002;17:576-84 (Pubitemid 36040974)
104. Galardi G, Perani D, Grassi F, et al. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Acta Neurol Scand 1996;94:172-6 (Pubitemid 26330356)
105. Carbon M, Su S, Dhawan V, et al. Regional metabolism in primary torsion dystonia: Effects of penetrance and genotype. Neurology 2004;62:1384-90 (Pubitemid 38526053)
106. Eidelberg D, Moeller JR, Antonini A, et al. Functional brain networks in DYT1 dystonia. Ann. Neurol. 1998;44:303-12 (Pubitemid 28421433)
107. Kerrison JB, Lancaster JL, Zamarripa FE, et al. Positron emission tomography scanning in essential blepharospasm. Am. J. Ophthalmol 2003;136:846-52 (Pubitemid 37330027)
108. Peller M, Zeuner KE, Munchau A, et al. The basal ganglia are hyperactive during the discrimination of tactile stimuli in writer's cramp. Brain 2006;129:2697-708 (Pubitemid 44522103)
109. Hu XY, Wang L, Liu H, et al. Functional magnetic resonance imaging study of writer's cramp. Chin Med J (Engl) 2006;119:1263-71
110. Blood AJ, Flaherty AW, Choi JK, et al. Basal ganglia activity remains elevated after movement in focal hand dystonia. Ann. Neurol. 2004;55:744-8 (Pubitemid 38544338)
111. Tolosa E, Compta Y. Dystonia in Parkinsons disease. J Neurol 2006;253(Suppl 7):VII7-13
112. Louis ED, Anderson KE, Moskowitz C, et al. Dystonia-predominant adult-onset Huntington disease: Association between motor phenotype and age of onset in adults. Arch Neurol 2000;57:1326-30
113. Louis ED, Lee P, Quinn L, et al. Dystonia in Huntington's disease: Prevalence and clinical characteristics. Mov Disord 1999;14:95-101 (Pubitemid 29224682)
114. Oliver J, Dewhurst K. Childhood and adolescent forms of Huntington's disease. J. Neurol. Neurosurg. Psychiatry 1969;32:455-9
115. Byers RK, Gilles FH, Fung C. Huntington's disease in children. Neuropathologic study of four cases. Neurology 1973;23:561-9
116. Lozano AM, Kumar R, Gross RE, et al. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord 1997;12:865-70 (Pubitemid 27496761)
117. Ford B. Pallidotomy for generalized dystonia. Adv Neurol 2004;94:287-99
118. Gross RE. What happened to posteroventral pallidotomy for Parkinsons disease and dystonia? Neurotherapeutics 2008;5:281-93 (Pubitemid 351446216)
119. Ostrem JL, Racine CA, Glass GA, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011;76:870-8
120. Isaias IU, Alterman RL, Tagliati M. Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol 2009;66:465-70
121. Bittar RG, Yianni J, Wang S, et al. Deep brain stimulation for generalised dystonia and spasmodic torticollis. J Clin Neurosci 2005;12:12-16 (Pubitemid 40082612)
122. Krauss JK, Loher TJ, Weigel R, et al. Chronic stimulation of the globus pallidus internus for treatment of non-dYT1 generalized dystonia and choreoathetosis: 2-year follow up.J Neurosurg 2003;98:785-92 (Pubitemid 36396780)
123. Capelle HH, Blahak C, Schrader C, et al. Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord 2010;25:1477-81
124. Chang EF, Schrock LE, Starr PA, et al. Long-term benefit sustained after bilateral pallidal deep brain stimulation in patients with refractory tardive dystonia. Stereotact Funct Neurosurg 2010;88:304-10
125. Gruber D, Trottenberg T, Kivi A, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology 2009;73:53-8
126. Usmani N, Bedi GS, Sengun C, et al. Late onset of cervical dystonia in a 39-year-old patient following cerebellar hemorrhage. J. Neurol. 2011;258:149-51
127. Waln O, LeDoux MS. Delayed-onset oromandibular dystonia after a cerebellar hemorrhagic stroke. Parkinsonism Relat. Disord. 2010;16:623-5
128. Zadro I, Brinar VV, Barun B, et al. Cervical dystonia due to cerebellar stroke. Mov Disord 2008;23:919-20
129. O'Rourke K, O'Riordan S, Gallagher J, et al. Paroxysmal torticollis and blepharospasm following bilateral cerebellar infarction. J. Neurol. 2006;253:1644-5 (Pubitemid 46115447)
130. Rumbach L, Barth P, Costaz A, et al. Hemidystonia consequent upon ipsilateral vertebral artery occlusion and cerebellar infarction. Mov Disord 1995;10:522-5
131. Krauss JK, Seeger W, Jankovic J. Cervical dystonia associated with tumors of the posterior fossa. Mov Disord 1997;12:443-7 (Pubitemid 27216149)
132. LeDoux MS, Brady KA. Secondary cervical dystonia associated with structural lesions of the central nervous system. Mov Disord 2003;18:60-9 (Pubitemid 36150208)
133. Caress JB, Nohria V, Fuchs H, et al. Torticollis acquired in late infancy due to a cerebellar gangliocytoma. Int J Pediatr Otorhinolaryngol 1996;36:39-44 (Pubitemid 26184723)
134. Alarcon F, Tolosa E, Munoz E. Focal limb dystonia in a patient with a cerebellar mass. Arch Neurol 2001;58:1125-7 (Pubitemid 32660776)
135. Draganski B, Thun-Hohenstein C, Bogdahn U, et al. "Motor circuit" gray matter changes in idiopathic cervical dystonia. Neurology 2003;61:1228-31 (Pubitemid 37377542)
136. Obermann M, Yaldizli O, De Greiff A, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord 2007;22:1117-23 (Pubitemid 47067221)
137. Delmaire C, Vidailhet M, Elbaz A, et al. Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology 2007;69:376-80 (Pubitemid 47205665)
138. Kluge A, Kettner B, Zschenderlein R, et al. Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia. Mov Disord 1998;13:125-34 (Pubitemid 28029863)
139. Yoon JH, Lee PH, Yoon SN. Subtraction brain SPECT imaging in a patient with paroxysmal exercise-induced dystonia: Role of the primary somatosensory cortex. Arch Neurol 2007;64:1652-6 (Pubitemid 350106768)
140. LeDoux MS, Rutledge SL, Mountz JM, et al. SPECT abnormalities in generalized dystonia. Pediatr Neurol 1995;13:5-10
141. Preibisch C, Berg D, Hofmann E, et al. Cerebral activation patterns in patients with writer's cramp: A functional magnetic resonance imaging study. J. Neurol. 2001;248:10-17 (Pubitemid 32245439)
142. Hutchinson M, Nakamura T, Moeller JR, et al. The metabolic topography of essential blepharospasm: A focal dystonia with general implications. Neurology 2000;55:673-7
143. Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740-7
144. Campbell DB, Hess EJ. Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse. Neuroscience 1998;85:773-83 (Pubitemid 28223639)
145. Chen G, Popa LS, Wang X, et al. Low-frequency oscillations in the cerebellar cortex of the tottering mouse. J Neurophysiol 2009;101:234-45
146. Brown LL, Lorden JF. Regional cerebral glucose utilization reveals widespread abnormalities in the motor system of the rat mutant dystonic. J Neurosci 1989;9:4033-41 (Pubitemid 20004897)
147. Richter A, Brotchie JM, Crossman AR, et al. [3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: Abnormalities in discrete brain regions of the motor system. Mov Disord 1998;13:718-25 (Pubitemid 28334109)
148. Pizoli CE, Jinnah HA, Billingsley ML, et al. Abnormal cerebellar signaling induces dystonia in mice. J Neurosci 2002;22:7825-33 (Pubitemid 35386381)
149. LeDoux MS, Lorden JF, Meinzen-Derr J. Selective elimination of cerebellar output in the genetically dystonic rat. Brain Res 1995;697:91-103
150. Devanagondi R, Egami K, LeDoux MS, et al. Neuroanatomical substrates for paroxysmal dyskinesia in lethargic mice. Neurobiol. Dis. 2007;27:249-57 (Pubitemid 47337187)
151. Campbell DB, North JB, Hess EJ. Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp Neurol 1999;160:268-78
152. Calderon DP, Fremont R, Kraenzlin F, et al. The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat Neurosci 2011;14:357-65
153. Baumer T, Demiralay C, Hidding U, et al. Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with writer's cramp. Mov Disord 2007;22:81-90 (Pubitemid 46382677)
154. Braun C, Schweizer R, Heinz U, et al. Task-specific plasticity of somatosensory cortex in patients with writer's cramp. Neuroimage 2003;20:1329-38 (Pubitemid 37268150)
155. Edwards MJ, Huang YZ, Mir P, et al. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov Disord 2006;21:2181-6 (Pubitemid 46140433)
156. Quartarone A, Morgante F, Sant'angelo A, et al. Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. J. Neurol. Neurosurg. Psychiatry 2008;79:985-90
157. Tamura Y, Ueki Y, Lin P, et al. Disordered plasticity in the primary somatosensory cortex in focal hand dystonia. Brain 2009;132:749-55
158. Mehrkens JH, Botzel K, Steude U, et al. Long-term efficacy and safety of chronic globus pallidus internus stimulation in different types of primary dystonia. Stereotact Funct Neurosurg 2009;87:8-17
159. Kohling R, Koch UR, Hamann M, et al. Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia. Neurobiol. Dis. 2004;16:236-45 (Pubitemid 38569814)
160. Martella G, Tassone A, Sciamanna G, et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: Role of endogenous acetylcholine. Brain2009;132:2336-49
161. Pisani A, Martella G, Tscherter A, et al.Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 2006;24:318-25 (Pubitemid 44572750)
162. Kreitzer AC, Malenka RC.Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinsons disease models. Nature 2007;445:643-7 (Pubitemid 46232883)
163. Ferre S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berl) 1997;133:107-20 (Pubitemid 27404740)
164. Elbert T, Candia V, Altenmuller E, et al. Alteration of digital representations in somatosensory cortex in focal hand dystonia. Neuroreport 1998;9:3571-5 (Pubitemid 28561744)
165. Granert O, Peller M, Gaser C, et al. Manual activity shapes structure and function in contralateral human motor hand area. Neuroimage 2011;54:32-41
166. Kang JS, Terranova C, Hilker R, et al. Deficient homeostatic regulation of practice-dependent plasticity in writer's cramp. Cereb Cortex 2011;21:1203-12
167. Byl NN, Merzenich MM, Jenkins WM. A primate genesis model of focal dystonia and repetitive strain injury: I. Learning-induced dedifferentiation of the representation of the hand in the primary somatosensory cortex in adult monkeys. Neurology 1996;47:508-20 (Pubitemid 26324052)
168. Alterman RL, Miravite J, Weisz D, et al. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 2007;69:681-8 (Pubitemid 47256011)
169. Sun B, Chen S, Zhan S, et al. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 2007;97:207-14
170. Bressman SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004;94:101-7
171. Kojovic M, Caronni A, Bologna M, et al. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord 2011;26:1282-9
172. Blomstedt P, Tisch S, Hariz MI. Pallidal deep brain stimulation in the treatment of Meige syndrome. Acta Neurol Scand 2008;118:198-202
173. Fukaya C, Katayama Y, Kano T, et al. Thalamic deep brain stimulation for writer's cramp. J Neurosurg 2007;107:977-82 (Pubitemid 350255212)
174. Reese R, Charron G, Nadjar A, et al. High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster. Neurobiol. Dis. 2009;35:399-405
175. Tisch S, Rothwell JC, Bhatia KP, et al. Pallidal stimulation modifies after-effects of paired associative stimulation on motor cortex excitability in primary generalised dystonia. Exp Neurol 2007;206:80-5 (Pubitemid 46935125)
176. Kuncel AM, Turner DA, Ozelius LJ, et al. Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome. Clin Neurol Neurosurg 2009;111:303-6
177. Panizza M, Lelli S, Nilsson J, et al. H-reflex recovery curve and reciprocal inhibition of H-reflex in different kinds of dystonia. Neurology 1990;40:824-8 (Pubitemid 20159622)
178. Nakashima K, Rothwell JC, Day BL, et al. Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain 1989;112:681-97 (Pubitemid 19151165)
179. Tisch S, Limousin P, Rothwell JC, et al. Changes in forearm reciprocal inhibition following pallidal stimulation for dystonia. Neurology 2006;66:1091-3 (Pubitemid 44044797)
180. Priori A, Berardelli A, Mercuri B, et al. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 1995;118:801-7
181. Ridding MC, Sheean G, Rothwell JC, et al. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J. Neurol. Neurosurg. Psychiatry 1995;59:493-8
182. Beck S, Shamim EA, Richardson SP, et al. Inter-hemispheric inhibition is impaired in mirror dystonia. Eur J Neurosci 2009;29:1634-40
183. Sohn YH, Hallett M. Disturbed surround inhibition in focal hand dystonia. Ann. Neurol. 2004;56:595-9 (Pubitemid 39319356)
184. Beck S, Houdayer E, Richardson SP, et al. The role of inhibition from the left dorsal premotor cortex in right-sided focal hand dystonia. Brain Stimul 2009;2:208-14
185. Matsumura M, Sawaguchi T, Oishi T, et al. Behavioral deficits induced by local injection of bicuculline and muscimol into the primate motor and premotor cortex. J Neurophysiol 1991;65:1542-53
186. Matsumura M, Sawaguchi T, Kubota K. GABAergic inhibition of neuronal activity in the primate motor and premotor cortex during voluntary movement. J Neurophysiol 1992;68:692-702
187. Deuschl G, Heinen F, Kleedorfer B, et al. Clinical and polymyographic investigation of spasmodic torticollis. J. Neurol. 1992;239:9-15
188. Muller J, Wissel J, Masuhr F, et al. Clinical characteristics of the geste antagoniste in cervical dystonia. J. Neurol. 2001;248:478-82 (Pubitemid 32661502)
189. Wissel J, Muller J, Ebersbach G, et al. Trick maneuvers in cervical dystonia: Investigation of movement- and touch-related changes in polymyographic activity. Mov Disord 1999;14:994-9
190. Naumann M, Magyar-Lehmann S, Reiners K, et al. Sensory tricks in cervical dystonia: Perceptual dysbalance of parietal cortex modulates frontal motor programming. Ann. Neurol. 2000;47:322-8 (Pubitemid 30141841)
191. Schramm A, Classen J, Reiners K, et al. Characteristics of sensory trick-like manoeuvres in jaw-opening dystonia. Mov Disord 2007;22:430-3 (Pubitemid 46569707)
192. Sheehy M, Marsden C. Writers' cramp - a focal dystonia. Brain 1982;105:465-80
193. Gomez-Wong E, Marti MJ, Tolosa E, et al. Sensory modulation of the blink reflex in patients with blepharospasm. Arch Neurol 1998;55:1233-7 (Pubitemid 28427495)
194. Yoneda Y, Rome S, Sagar HJ, et al. Abnormal perception of the tonic vibration reflex in idiopathic focal dystonia. Eur J. Neurol. 2000;7:529-33 (Pubitemid 32530114)
195. Frima N, Nasir J, Grunewald RA. Abnormal vibration-induced illusion of movement in idiopathic focal dystonia: An endophenotypic marker? Mov Disord 2008;23:373-7
196. Kaji R, Rothwell JC, Katayama M, et al. Tonic vibration reflex and muscle afferent block in writer's cramp. Ann. Neurol. 1995;38:155-62
197. Rosenkranz K, Williamon A, Butler K, et al. Pathophysiological differences between musician's dystonia and writer's cramp. Brain 2005;128:918-31 (Pubitemid 40516928)
198. Tamburin S, Manganotti P, Marzi CA, et al. Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patients. Brain 2002;125:2719-30 (Pubitemid 35423521)
199. Bara-Jimenez W, Catalan MJ, Hallett M, et al. Abnormal somatosensory homunculus in dystonia of the hand. Ann. Neurol. 1998;44:828-31 (Pubitemid 28516057)
200. Nelson AJ, Blake DT, Chen R. Digit-specific aberrations in the primary somatosensory cortex in Writer's cramp. Ann. Neurol. 2009;66:146-54
201. Lim J, Hao T, Shaw C, et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006;125:801-14 (Pubitemid 43732348)
202. Vila M, Przedborski S. Genetic clues to the pathogenesis of Parkinsons disease. Nat Med 2004;10(Suppl):S58-62 (Pubitemid 38901868)
203. Stone EA, Lin Y, Quartermain D. A final common pathway for depression? Progress toward a general conceptual framework. Neurosci Biobehav Rev 2008;32:508-24 (Pubitemid 351173335)
204. Benatar M. Lost in translation: Treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 2007;26:1-13 (Pubitemid 46437445)
205. Friese MA, Montalban X, Willcox N, et al. The value of animal models for drug development in multiple sclerosis. Brain 2006;129:1940-52 (Pubitemid 44289061)